Skip to main content
News LEO Foundation and LEO Pharma - adviser to LEO Foundation and LEO Pharma in connection with Nordic Capital's EUR 450 million investment in LEO Pharma
Menu
  • Our people
  • Practice areas
  • Level 2
    • Working with us
    • Open positions
    LinkedIn Instagram Alumni
  • Level 2
    • News
    • Training and education
    • Sign up for newsletters
    LinkedIn Instagram Alumni
  • Level 2
    • Who we are
    • Culture
    • The Plesner Way
    • Global working
    • Leadership
    • Our story
    LinkedIn Instagram Alumni
  • Level 2
    • Our commitments
    • Sustainability
    • Diversity and inclusion
    • Pro bono
    LinkedIn Instagram Alumni
  • Contact
Search
LinkedIn Instagram Sign up for newsletters

LEO Foundation and LEO Pharma - adviser to LEO Foundation and LEO Pharma in connection with Nordic Capital's EUR 450 million investment in LEO Pharma

Case News
Share
LinkedIn Send via email

Latest news

Plesner News
11.04.2025

Plesner wins three awards at the 2025 Managing IP EMEA Awards

Plesner News
04.04.2025

Plesner wins prestigious "National Law Firm of the Year" award

Plesner News
26.03.2025

Plesner achieves top-tier rankings in Legal 500

See all
Sofa og bord
More from Plesner

Stay updated with the latest news from Plesner

Sign up for newsletters
Follow us on Instagram
Follow us on LinkedIn
Plesner Advokatpartnerselskab
Amerika Plads 37
2100 Copenhagen Ø
+45 33 12 11 33
plesner@plesner.com
  • Business terms
  • Disclaimer
  • Privacy policy
  • Duty to provide information
  • Anti-bribery policy
  • Rules against money laundering
  • Press